Leadership Team

Dr. Hixson serves as the company's Chief Executive Officer and has served as Chairman of the Board of Directors since 2003. He recently served on the Board of directors of BrainCells, Inc., a biopharmaceutical company focused on central nervous system drug development, where he was Chief Executive Officer from July 2004 until September 2005. Dr. Hixson served as Chief Executive Officer of Elitra Pharmaceuticals, Inc., a biopharmaceutical company focused on anti-infective drug development, from February 1998 until May 2003. He served as President and Chief Operating Officer of Amgen Inc., and was a member of its board of directors from 1988 to 1991. Prior to Amgen, Dr. Hixson held various management positions with Abbott Laboratories, including Vice President, Diagnostic Products Business Group, and Vice President, Research and Development, in the Diagnostics Division. Dr. Hixson also is a Director of Arena Pharmaceuticals, Inc. Dr. Hixson received his Ph.D. in Physical Biochemistry from Purdue University and an M.B.A. from the University of Chicago.

Dr. Lindsay serves as Sequenom's Executive Vice President, Strategic Planning, previously serving as Executive Vice President of Research and Development. Dr. Lindsay has been a Director since 2003. He served as Vice President, Research and Development, and Chief Science Officer of diaDexus Inc., a biotechnology company, from 2000 to January 2004. From 1997 through 2000, Dr. Lindsay served in various senior management roles with Millennium Pharmaceuticals, Inc., a biopharmaceutical company. From 1989 to 1997, Dr. Lindsay served in various roles with Regeneron Pharmaceuticals Inc., of which he was a founding scientist. He is a director of Arqule Inc., and HistoRx Inc. and received his Ph.D. in Biochemistry from the University of Calgary.

Mr. Maier serves as Sequenom's chief financial officer. Mr. Maier served as senior vice president and chief financial officer of Ligand Pharmaceuticals Incorporated from 1992 until January 2007, where he helped build Ligand from a venture stage company to a commercial, integrated biopharmaceutical organization. During his tenure at Ligand, Mr. Maier helped raise over $1 billion in equity and debt financings. Prior to Ligand, Mr. Maier spent six years in various management and finance positions at ICN Pharmaceuticals. Mr. Maier currently serves as a director of Apricus Biosciences, Talon Therapeutics, Pure Bioscience, and International Stem Cell Corporation. Mr. Maier received his M.B.A. from Harvard University.

Allan T. Bombard, M.D. is chief medical officer, Sequenom, Inc. as well as visiting professor, obstetrics and gynecology, Albert Einstein College of Medicine and Clinical Professor at the University of California San Diego.

Prior to joining Sequenom, Dr. Bombard was chief executive officer, Lenetix Medical Screening Laboratories, Inc. in Mineola, New York, where he transitioned from his role as chief medical Officer, Sharp Mary Birch Hospital in San Diego, CA. Before joining Sharp Healthcare Dr. Bombard was senior vice president, chair and residency program director, department of Ob/Gyn at Lutheran Medical Center, Brooklyn, NY. Dr. Bombard came to Lutheran Medical Center from Aetna, Inc., where he served as the Western U.S. medical director for women’s health. Before working for Aetna, he served as professor & director, reproductive genetics, department of Ob/Gyn & women’s health at Montefiore Medical Center and the Albert Einstein College of Medicine in Bronx, New York. He attained the academic rank of professor at the medical school in 1997.

Dr. Bombard received his Bachelor of Arts degree from Colgate University, his Doctor of Medicine degree from the George Washington University, and his Masters in Business Administration from the University of San Diego. He completed a residency in Ob/Gyn at the Wilford Hall USAF Medical Center in San Antonio, Texas, and his fellowship in Clinical Genetics at Northwestern University in Chicago, Illinois. Dr. Bombard is board certified in both Clinical Genetics as well as Obstetrics & Gynecology.

Dr. Bombard retired from the USAF Reserves in 2002 with the rank of Colonel and served in Operation Desert Storm. He is a Founding Fellow of the American College of Medical Genetics, a Fellow of the American College of Obstetricians & Gynecologists, a member of the American Medical Association, and a life member of the American College of Physician Executives. He serves on a number of national professional committees and has lectured extensively on a variety of women’s health issues including genetic counseling, prenatal screening & diagnosis, the business of medicine, and BRCA screening. His articles have appeared in peer-reviewed medical journals such as the Lancet and the American Journal of Obstetrics & Gynecology.

Dr. Cantor joined the company as chief scientific officer in 1998. He was previously the chair and professor of the department of biomedical engineering and biophysics, and director of the Center for Advanced Biotechnology at Boston University. Prior to that time, Dr. Cantor held positions at Columbia University and the University of California, Berkeley. He was also director of the Human Genome Center Project of the Department of Energy at Lawrence Berkeley Laboratory. A world-renowned scientist, Dr. Cantor is a consultant to more than 16 biotech firms, has published more than 400 peer reviewed articles, been granted 54 US patents, and co-authored a three-volume textbook on Biophysical Chemistry. He published the first textbook on genomics entitled, Genomics: The Science and Technology of the Human Genome Project.

Mr. Michael Monko joined Sequenom in August 2006. Mr. Monko has 20 years of life science sales and marketing experience. He served as vice president of sales for Upstate/Chemicon with global sales and management responsibility for more than 100 sales, service and support employees. Previously, he served 19 years at Invitrogen Corporation with a progressive and accomplished career in sales, beginning as a representative and culminating as senior director, sales force effectiveness.

Mr. Monko earned an M.B.A. from Babson College and B.S. in biochemistry from University of New Hampshire.

Ms. Alisa Judge brings over 20 years of human resources experience having previously served as vice president of human resources at Claritas, a division of the Nielsen Company, the world's leading provider of marketing information and audience measurement, prior to Claritas, Ms. Judge held the same role for GKN Aerospace Chem-tronics, a leading global supplier to the world's automotive and aerospace manufacturers. Prior to GKN, she was Director of Global Staffing and Retention at Invitrogen Corp., a global biotech manufacturer based in Carlsbad, Calif. She also held the title of Vice President, Human Resources, at Advanced Marketing Services, Inc., where she spent 10 years. The San Diego-based company provided wholesaling and distribution services to book retailers.